Author

Paul A Gurbel

Sinai Center for Thrombosis Research and Drug Development - Cited by 45,480 - Thrombosis - Cardiology

Biography

Dr. Gurbel reports grants and personal fees from Bayer HealthCare LLC Paul A Gurbel wrks as a assistant professor at Sinai Center for Thrombosis Research, Sinai Hospital of Baltimore, West Belvedere, Avenue, Baltimore, MD, USA have area of intrest include:-P2Y12 receptor; Clopidogrel; CYP2C19; Ticagrelor  
Title
Cited by
Year
Current and novel biomarkers of thrombotic risk in COVID-19: a Consensus Statement from the International COVID-19 Thrombosis Biomarkers Colloquium
DA Gorog, RF Storey, PA Gurbel, US Tantry, JS Berger, MY Chan, ...Nature Reviews Cardiology 19 (7), 475-495, 2022202
148
2022
Cardiac mortality in patients randomised to elective coronary revascularisation plus medical therapy or medical therapy alone: a systematic review and meta-analysis
EP Navarese, AJ Lansky, DJ Kereiakes, J Kubica, PA Gurbel, DA Gorog, ...European heart journal 42 (45), 4638-4651, 2021202
74
2021
Pharmacodynamic profile and prevalence of bleeding episode in East Asian patients with acute coronary syndromes treated with prasugrel standard-dose versus de-escalation …
YH Jeong, JH Oh, HJ Yoon, Y Park, J Suh, SW Lee, K Lee, JS Kim, ...Thrombosis and Haemostasis 121 (10), 1376-1386, 2021202
16
2021
PCSK9 inhibition during the inflammatory stage of SARS-CoV-2 infection
EP Navarese, P Podhajski, PA Gurbel, K Grzelakowska, E Ruscio, ...Journal of the American College of Cardiology 81 (3), 224-234, 2023202
15
2023
Thrombogenicity markers for early diagnosis and prognosis in COVID-19: a change from the current paradigm?
PA Gurbel, KP Bliden, JH Levy, N Walia, N Rapista, A Cho, C Jerjian, ...Blood Coagulation & Fibrinolysis 32 (8), 544, 2021202
13
2021
International COVID-19 thrombosis biomarkers colloquium: COVID-19 diagnostic tests
PA Gurbel, US Tantry, RF StoreyJournal of Thrombosis and Thrombolysis 52 (4), 992-998, 2021202
11
2021
Aspirin as an adjunctive pharmacologic therapy option for COVID-19: anti-inflammatory, antithrombotic, and antiviral effects all in one agent
US Tantry, K Schror, EP Navarese, YH Jeong, J Kubica, KP Bliden, ...Journal of Experimental Pharmacology, 957-970, 2021202
11
2021
Clopidogrel resistance and clopidogrel treatment failure
US Tantry, CH Hennekens, JL Zehnder, PA Gurbel, D CutlipLeung, LLK, Cutlip, D., Eds, 2023202
8
2023
Metformin use in patients hospitalized with COVID-19: lower inflammation, oxidative stress, and thrombotic risk markers and better clinical outcomes
A Usman, KP Bliden, A Cho, N Walia, C Jerjian, A Singh, P Kundan, ...Journal of Thrombosis and Thrombolysis 53 (2), 363-371, 2022202
8
2022
Low-dose ticagrelor with or without acetylsalicylic acid in patients with acute coronary syndrome: Rationale and design of the ELECTRA-SIRIO 2 trial
J Kubica, P Adamski, DA Gorog, A Kubica, B Jilma, A Budaj, ...Cardiology journal 29 (1), 148-153, 2022202
7
2022
Measurement of anticoagulation in patients on dabigatran, rivaroxaban, and apixaban therapy by novel automated thrombelastography
R Artang, JD Dias, M Walsh, K Bliden, JD Nielsen, M Anderson, ...TH Open 5 (04), e570-e57, 2021202
6
2021
Sex-related differences in clinical outcomes among patients with myocardial infarction with nonobstructive coronary artery disease: a systematic review and meta-analysis
R Chaudhary, M Bashline, EM Novelli, KP Bliden, US Tantry, O Olafiranye, ...International Journal of Cardiology, 2022202
6
2022
The prognostic role of ST2L and sST2 in patients who underwent carotid plaque endarterectomy: a five-year follow-up study
P Scicchitano, A Marzullo, A Santoro, A Zito, F Cortese, C Galeandro, ...Journal of Clinical Medicine 11 (11), 3142, 2022202
6
2022
The role of viscoelastic testing in assessing peri-interventional platelet function and coagulation
US Tantry, J Hartmann, MD Neal, H Schöechl, KP Bliden, S Agarwal, ...Platelets 33 (), 520-530, 2022202
4
2022
Prognostic impact of hypercoagulability and impaired fibrinolysis in acute myocardial infarction
SH Lee, HK Kim, JH Ahn, MG Kang, KH Kim, JS Bae, SY Cho, JS Koh, ...European Heart Journal (19), 1718-1728, 2023202
4
2023
Further evidence for the use of aspirin in COVID-19
US Tantry, KP Bliden, PA GurbelInternational Journal of Cardiology 346, 107-108, 0
2
2022
Residual inflammatory risk and its association with events in East Asian patients after coronary intervention
JH Ahn, US Tantry, MG Kang, HW Park, JS Koh, JS Bae, SY Cho, KH Kim, ...JACC: Asia (3_Part_), 33-337, 0
2
2022
Bleeding and ischemic outcomes with ticagrelor monotherapy according to body mass index
V Kunadian, U Baber, CA Pivato, D Cao, G Dangas, S Sartori, Z Zhang, ...Cardiovascular Interventions 15 (19), 1948-1960, 0
2
2022
In Vitro Evidence for the Role of Cytokine Storm in the Generation of Stent Thrombosis in COVID-19 Patients
In Vitro Evidence for the Role of Cytokine Storm in the Generation of Stent Thrombosis in COVID-9 PatientsPA Gurbel, US TantryCardiovascular Revascularization Medicine 35, 39, 2022202
1
2022
metformin use in patients hospitalized with COVID-19: lower inflammation, oxidative stress, and thrombotic risk markers and better clinical outcomes
metformin use in patients hospitalized with COVID-9: lower inflammation, oxidative stress, and thrombotic risk markers and better clinical outcomesK Bliden, U Tantry, A Usman, A Cho, N Walia, C Jerijan, A Singh, ...Circulation 44 (Suppl_), A2228-A2228, 20220
1
2021

Referred From: https://scholar.google.com/citations?user=xHWLE8UAAAAJ&hl=en

Cited by
Citations 45480
h-index 92
i10-index 371
Recommended Journals
Open Access Journals